9379 results about "Long chain" patented technology

The present invention comprises methods and compositions for antimicrobial silver compositions comprising silver nanoparticles. The present invention further comprises compositions for preparing silver nanoparticles comprising at least one stabilizing agent, one or more silver compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the silver compound comprises a salt comprising a silver cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates. The methods of the present invention comprise treating devices with the silver nanoparticle compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices. The present invention further comprises treatment of humans and animals wacr6ith the antimicrobial devices described herein.

Antimicrobial compositions, especially those useful when applied topically, particularly to mucosal tissues (i.e., mucous membranes), including a cationic antiseptic such as biguanides and bisbiguanides such as chlorhexidine and its various salts including but not limited to the digluconate, diacetate, dimethosulfate, and dilactate salts; polymeric quaternary ammonium compounds such as polyhexamethylenebiguanide; silver and various silver complexes; small molecule quaternary ammonium compounds such as benzalkoium chloride and alkyl substituted derivatives; di-long chain alkyl (C8-C18) quaternary ammonium compounds; cetylpyridinium halides and their derivatives; benzethonium chloride and its alkyl substituted derivatives; and octenidine. The compositions can also include an enhancer component, a surfactant, a hydrophobic component, and / or a hydrophilic component. Such compositions provide effective topical antimicrobial activity and are accordingly useful in the treatment and / or prevention of conditions that are caused, or aggravated by, microorganisms (including viruses).

The present invention comprises methods and compositions comprising metal nanoparticles. The invention comprises metal nanoparticles and surfaces treated with a metal nanoparticle coating. The present invention further comprises compositions for preparing nanoparticles comprising at least one stabilizing agent, one or more metal compounds, at least one reducing agent and a solvent. In one aspect, the stabilizing agent comprises a surfactant or a polymer. The polymer may comprise polymers such as polyacrylamides, polyurethanes, and polyamides. In one aspect, the metal compound comprises a salt comprising a metal cation and an anion. The anion may comprise saccharinate derivatives, long chain fatty acids, and alkyl dicarboxylates.

The present invention relates to an olefin metathesis reaction catalyst where rhenium (Re) oxide or molybdenum (Mo) oxide is supported, as a catalyst main component, on a surface-modified mesoporous silica or mesoporous alumina support, and a preparation method therefor. The olefin metathesis reaction catalyst of the present invention allows highly efficient metathesis of long-chain unsaturated hydrocarbons having at least eight carbons at a low temperature of 150° C. or lower. The catalyst can be separated readily from reaction solution, regenerated at a low temperature of 400° C. or lower by removing toxins accumulated on it during the metathesis reaction, and used repeatedly in metathesis reaction many times, thereby being made good use in commercial olefin metathesis processes.

A composition for topical application of a botulinum toxin (including botulinum toxin derivatives) comprises a botulinum toxin and a carrier comprising a polymeric backbone comprising a long-chain polypeptide or nonpeptidyl polymer having attached positively charged branching or “efficiency” groups. The invention also relates to methods for reducing muscle paralysis and other conditions that may be treated with a botulinum toxin, particularly paralysis of subcutaneous, and most particularly, facial, muscles, by topically applying an effective amount of the botulinum toxin and carrier, in conjunction, to the subject's skin or epithelium. Kits for administration are also described.

Several novel PHA polymer compositions produced using biological systems include monomers such as 3-hydroxybutyrate, 3-hydroxypropionate, 2-hydroxybutyrate, 3-hydroxyvalerate, 4-hydroxybutyrate, 4-hydroxyvalerate and 5-hydroxyvalerate. These PHA compositions can readily be extended to incorporate additional monomers including, for example, 3-hydroxyhexanoate, 4-hydroxyhexanoate, 6-hydroxyhexanoate or other longer chain 3-hydroxyacids containing seven or more carbons. This can be accomplished by taking natural PHA producers and mutating through chemical or transposon mutagenesis to delete or inactivate genes encoding undesirable activities. Alternatively, the strains can be genetically engineered to express only those enzymes required for the production of the desired polymer composition. Methods for genetically engineering PHA producing microbes are widely known in the art (Huisman and Madison, 1998, Microbiology and Molecular Biology Reviews, 63: 21-53). These polymers have a variety of uses in medical, industrial and other commercial areas.

An electronic device module comprising:A. At least one electronic device, e.g., a solar cell, andB. A polymeric material in intimate contact with at least one surface of the electronic device, the polymeric material comprising (1) an ethylene-based polymer composition characterized by a Comonomer Distribution Constant greater than about 45, more preferably greater than 50, most preferably greater than 95, and as high as 400, preferably as high as 200, wherein the composition has less than 120 total unsaturation unit / 1,000,000C, preferably the ethylene-based polymer compositions comprise up to about 3 long chain branches / 1000 carbons, more preferably from about 0.01 to about 3 long chain branches / 1000 carbons; the ethylene-based polymer composition can have a ZSVR of at least 2; the ethylene-based polymer compositions can be further characterized by comprising less than 20 vinylidene unsaturation unit / 1,000,000C; the ethylene-based polymer compositions can have a bimodal molecular weight distribution (MWD) or a multi-modal MWD; the ethylene-based polymer compositions can have a comonomer distribution profile comprising a mono or bimodal distribution from 35° C. to 120° C., excluding purge; the ethylene-based polymer compositions can comprise a single DSC melting peak; the ethylene-based polymer compositions can comprise a weight average molecular weight (Mw) from about 17,000 to about 220,000, (2) optionally, a vinyl silane, (3) optionally, a free radical initiator, e.g., a peroxide or azo compound, or a photoinitiator, e.g., benzophenone, and (4) optionally, a co-agent.

A high strength abrasion resistant surgical suture material with improved tie down characteristics is color coded for visualization and identification purposes. The suture features a multifilament cover formed of strands of ultra high molecular weight long chain polyethylene braided with polyester, nylon or a bioabsorbable material. Selected nylon fibers in the cover are provided in a color contrasting with the other cover fibers to provide an identifiable trace. The cover surrounds a core formed of twisted strands of ultrahigh molecular weight polyethylene. The suture, provided in a #2 size, has the strength of #5 Ethibond, is ideally suited for most orthopedic procedures, and can be attached to a suture anchor or a curved needle.

The invention relates to a method for the production of a branched polycarbonate composition, having increased melt strength, by late addition of branch-inducing catalysts to the polycarbonate oligomer in a melt polycondensation process. Surprisingly, it has been found that by adding branch-inducing catalysts, such as alkali metal compounds and / or alkaline earth metal compounds, to the melt polycarbonate oligomer at a later stage of the melt polycondensation process, preferably after the oligomer has reached an average molecular weight of between about 3,000 and 30,000 g / mole, a unique branched polycarbonate composition is formed that has improved properties. It is believed that the addition of the branch-inducing catalysts at the later stages of the process produces a branched polycarbonate composition having longer chains between the branching points, and thus a new composition is produced. The invention also relates to various applications of the branched polycarbonate composition.

The invention relates to a perovskite / polymer composite luminescent material and a preparation method thereof, which belong to the technical field of composite materials and luminescent materials, wherein the structural formula of the perovskite is R1NH3AB3 or (R2NH3)2AB4, A and B form a ligand octahedral structure, R1NH3 or R2NH3 are filled into gaps of the ligand octahedral structure which is formed through the A and the B, R1 is methyl, R2 is a long-chain organic molecular group, the A is any one of metal Ge, Sn, Pb, Cu, Mn, Sb and Bi, the B is any one of Cl, Br and I. The perovskite / polymer composite luminescent material which is made through the preparation method is high in luminescent intensity, high in luminescent color purity, excellent in light and thermal stability and excellent chemical resistant property and mechanical property, and lays the foundation for theory research and application of the perovskite / polymer composite luminescent material in high-performance photoluminescence devices, flexible display, lasers, nonlinear optical devices. The preparation method can obtain composite materials which can cover a whole visible region through luminescent wavelengths, and has wide application prospect in the fields of wide gamut light emitting diode (LED) and high performance displays and the like.

The present invention includes a palatable, stable composition comprising a biomass hydrolysate emulsion for incorporation, into, or used as, nutritional products, cosmetic products or pharmaceutical products. Preferred sources for biomass are microbial sources, plant sources and animal sources. The present invention also provides methods for making such compositions, specifically, a method for producing a product comprising a nutrient, particularly a long chain polyunsaturated fatty acid, comprising hydrolyzing a biomass comprising the nutrient and emulsifying the hydrolyzed biomass. Such compositions and methods are useful, for example, for increasing intake of nutrients such as omega-3 long chain polyunsaturated fatty acids having 18 or more carbons.

The invention relates to a method for generating the high quality ethylene raw material through naphtha hydrogenation. The method takes naphtha fraction and animal and vegetable oil as the raw material oil, under the condition of hydrofining, the raw material oil and hydrogen are mixed and passed through a hydrofining reaction area, the hydrogen-rich gas recycling utilization can be acquired through separating the hydrofining generated oil, and low Sulfur, low hydrogen and low aromatic naphtha can be acquired through removing hydrogen sulfide of the separated liquid with an air stripping tower. Compared with the prior art, the method has the advantages that the oil is mixed in the naphtha hydrogenation raw material, the quality of the product as the ethylene cracking raw material, in particular to aromatic long chain hydrocarbon nC16 to 18 and propane acquired through the animal and vegetable oil hydrogenation, can be remarkably improved, the cracking furnace ethylene output can be increased and the cracking furnace life can be prolonged through adding the aromatic long chain hydrocarbon nC16 to 18 and propane in the ethylene cracking raw material.

The present invention relates generally to formulations for transdermal or transmucosal administration of an active agent. The invention is a substantially malodorous-free and irritation free transdermal formulation which is substantially free of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters.

A self-emulsifying drug delivery system to improve dissolution, stability, and bioavailability of drug compounds of dronabinol or other cannabinoids. The drug compound(s) are dissolved in an oily medium (e.g. triglycerides and / or mixed glycerides and / or free fatty acids containing medium and / or long chain saturated, mono-unsaturated, and / or poly-unsaturated free fatty acids) together with at least one surfactant. The surfactant promotes self-emulsification, thereby promoting targeted chylomicron delivery and optimal bioavailability to a mammalian intestinal lumen. A dosage form can optionally include co-solvents, anti-oxidants, viscosity modifying agents, cytochrome P450 metabolic inhibitors, P-GP efflux inhibitors, and amphiphilic / non-amphiphilic solutes to induce semi-solid formation for targeted release rates.

The present invention provides a surfactant blend that includes an extended chain surfactant and high HLB nonionic surfactant. The surfactant blend may be incorporated into household and industrial-institutional cleaning products to solubilize hard to remove oily stains and soil from a variety of surfaces.

The present invention relates to methods of synthesizing long-chain polyunsaturated fatty acids, especially eicosapentaenoic acid, docosapentaenoic acid and docosahexaenoic acid, in recombinant cells such as yeast or plant cells. Also provided are recombinant cells or plants which produce long-chain polyunsaturated fatty acids. Furthermore, the present invention relates to a group of new enzymes which possess desaturase or elongase activity that can be used in methods of synthesizing long-chain poly unsaturated fatty acids.

This invention relates to catalyst compositions, methods, and polymers encompassing a Group 4 metallocene with bridging η5-cyclopentadienyl-type ligands, in combination with a cocatalyst and an activator-support. The compositions and methods disclosed herein provide ethylene polymers with low levels of long chain branching.

This invention relates to catalyst compositions, methods, and polymers encompassing a Group 4 metallocene with bridging η5-cyclopentadienyl-type ligands, in combination with a cocatalyst and an activator-support. The compositions and methods disclosed herein provide ethylene polymers with low levels of long chain branching.

The present invention provides methods and compositions comprising at least one perhydrolase enzyme for cleaning and other applications. In some embodiments, the present invention provides methods and compositions for generation of long chain peracids. Certain embodiments of the present invention find particular use in applications involving cleaning, bleaching and disinfecting.

The invention discloses a water soluble full-alloy metal grinding fluid which belongs to the technical field of metal grinding fluids. The metal grinding fluid is prepared from the following components in percentage by weight: 5-40wt% of an antirust agent, 1-20wt% of a cleaning agent, 0.1-10wt% of a lubricating corrosion inhibitor, 1-20wt% of a penetrant, 1-20wt% of a solubilizer, 10-40wt% of a PH adjustor, 0.5-5wt% of a defoamer and the balance of water. Based on the total weight of the water soluble full-alloy metal grinding fluid, the pH value of the water soluble full-alloy metal grinding fluid is 7-11. The lubricating corrosion inhibitor is long chain nitrogen heterocyclic ring organic ester. The water soluble full-alloy metal grinding fluid has excellent lubricating, rust-preventing, cleaning and cooling performances and can be widely applied to grinding of ferrous metals and nonferrous metals.

The invention discloses a block chain generation method, a data verification method, nodes and a system. The block chain generation method is used for increasing the utilization rate of a storage space and is applied to a block chain system containing M nodes. According to each of the M nodes, the block chain generation method comprises the steps that N pieces of fingerprint information corresponding to N pieces of to-be-written data are acquired, wherein N is greater than or equal to 1; a new block is constructed, wherein the new block comprises a data set and a block head; the data set comprises N pieces of fingerprint information; the block head comprises a Hash value of a block head of a previous block in a local block chain of the node, wherein the previous block is a newly added block in a longest chain of the local block chain; and through a consensus algorithm, a consensus block is determined from new blocks generated by M nodes and is added into the local block chain. In thisway, the storage space occupied by other information of non-to-be-written data in transaction information is saved, and therefore the utilization rate of the storage space and is increased.

The present invention has an object of providing a carbon nanotube dispersed composite material utilizing as much as possible excellent electric conductivity, heat conductive property and strength property owned by a carbon nanotube itself and taking advantage of features of ceramics having corrosion resistance and heat resistance such as zirconia and the like, and a method of producing the same; and long-chain carbon nanotubes (including also those obtained by previous discharge plasma treatment of only carbon nanotubes) are kneaded and dispersed by a ball mill, planet mill and the like together with calcinable ceramics and metal powder, further, the knead-dispersed material is treated by discharge plasma and this is integrated by sintering by discharge plasma, and carbon nanotubes can be thus dispersed in the form of network in the sintered body, and the electric conductivity property, heat conductive property and strength property of the carbon nanotube can be effectively used together with the properties of the ceramics and metal powder base material.

A nutritional supplement comprising an infant milk formula having long chain poly unsaturated fatty acids, sialic acids, and cholesterol.

Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-9 elongases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these delta-9 elongases in plants.